Neion Bio raises $23M Series A to make proteins from chicken eggs

Neion extracts primordial germ cells from a fertilized egg in its genetic engineering process (Credit: Marco Figueroa) June 11, 2026 07:00 AM EDT PharmaManufacturing Neion Bio lands $23M Se­ries A to make pro­teins from chick­en eggs Anna Brown News Reporter Neion Bio has se­cured an over­sub­scribed $23 mil­lion Se­ries A to fur­ther de­vel­op its tech­nol­o­gy that us­es chick­en eggs to make ac­tive phar­ma­ceu­ti­cal in­gre­di­ents for … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER